← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cognetix, Inc.
Salt Lake City, UT
$1,613,804
Total funding
12
Grants
Funding mix
By agency
NIH$1,613,804 · 12
By mechanism
R43$988,804 · 10
R44$625,000 · 2
Investigators at Cognetix, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
CONANTOKINS FOR TREATMENT OF EPILEPSY$375,000
R44 · FY2000 · NS
IN VITRO FLUOROTEST FOR ENVIRONMENTAL/AGROCHEMICALS$250,000
R44 · FY2000 · ES
Conopeptides as Topical Local Anesthetics for Burn Pain$100,000
R43 · FY2001 · GM
Cone Snail Venom mGluRl Antagonist for Chronic Pain$100,000
R43 · FY2001 · NS
CGX-1160, a non-opioid, broad-spectrum analgesic$100,000
R43 · FY2001 · DA
AMPA receptor blocking peptides for chronic pain$99,900
R43 · FY2002 · DE
KAPPA-PVIIA$99,748
R43 · FY2000 · HL
THERAPEUTIC POTENTIAL OF KAPPA-PVIIA$99,700
R43 · FY2000 · AI
CONOPEPTIDES AS SELECTIVE NICOTINIC RECEPTOR MODULATORS$99,475
R43 · FY2000 · NS
LEADS FOR ALZHEIMER'S DISEASE FROM CONOPEPTIDE LIBRARIES$98,702
R43 · FY2000 · AG
ALPHA-CONOPEPTIDES: NOVEL RAPID-ACTING MUSCLE RELAXANTS$97,051
R43 · FY2000 · GM
CONOPEPTIDE SODIUM CHANNEL BLOCKERS FOR CHRONIC PAIN$94,228
R43 · FY2000 · NS